Net At Work continues its aggressive acquisition strategy with the purchase of LLB Partners, marking its third deal in under three months. The move strengthens the company’s position in the competitive ERP consulting space while expanding service capabilities around Sage and Acumatica platforms.
JPMorgan has successfully tokenized a private equity fund using its in-house blockchain platform, marking a significant milestone in Wall Street’s embrace of blockchain technology. The move precedes a wider rollout of their Kinexys Fund Flow platform next year.
Apple continues its experimental browser development with Safari Technology Preview 231, featuring critical fixes across multiple web technologies. This developer-focused release tests features destined for future Safari versions while maintaining compatibility with the latest macOS systems.
While US politicians warn about China’s surveillance state, American technology continues to power it through a critical cloud computing loophole. Four legislative attempts to close this gap have failed amid intense industry lobbying, raising serious national security concerns.
Reddit’s third-quarter earnings reveal a complex story of financial success paired with concerning user growth trends. While revenue surged 68% and the company beat analyst expectations, logged-in user growth continues to decelerate, raising questions about long-term sustainability.
As AI data centers strain power grids, Bloom Energy is positioning fuel cells as the solution. The company’s ambitious expansion and strategic partnerships signal a fundamental shift in how we power the digital economy.
onsemi has introduced vertical gallium nitride power semiconductors that promise to revolutionize power efficiency in AI data centers and electric vehicles. The proprietary GaN-on-GaN technology achieves 50% energy loss reduction while shrinking component sizes dramatically. This breakthrough could
Researchers have developed a revolutionary approach to drug discovery that eliminates the need for DNA barcodes. The method uses mass spectrometry to screen hundreds of thousands of compounds, potentially making drug development faster and more accessible.
In a stunning reality check for AI automation ambitions, new research reveals that leading AI agents failed spectacularly at performing actual freelance work. The top performer managed just 2.5% of tasks at acceptable quality levels.
The AI investment boom is creating clear winners and potential losers as companies take radically different approaches to capital expenditure. Microsoft’s demand-driven strategy contrasts sharply with Meta’s speculative building as depreciation costs surge.
